Promising developments bringing prion diseases closer to therapy and prophylaxis

Trends in Molecular Medicine

Volumn 9, Issue 9, 2003, Pages 367-369

  Gilch, Sabine ^a   Schätzl, Hermann M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIBODY; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; PRION PROTEIN;

BIOASSAY; CLINICAL TRIAL; HUMAN; IMMUNE SYSTEM; IMMUNOBLOTTING; NONHUMAN; PRION DISEASE; REVIEW; VACCINATION;

MUS MUSCULUS;

EID: 0141793055     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(03)00144-8     Document Type: Short Survey

References (25)

1. Prusiner, S.B. (1998) Prions. Proc. Natl. Acad. Sci. U. S. A. 95, 13363-13383
2. Weissmann, C. et al. (2001) Prions and the lymphoreticular system. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356, 177-184
3. Clarke, A.R. et al. (2001) The molecular biology of prion propagation. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356, 185-195
4. Cohen, F.E. et al. (1994) Structural clues to prion replication. Science 264, 530-531
5. Come, J.H. et al. (1993) A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc. Natl. Acad. Sci. U. S. A. 90, 5959-5963
6. Head, M.W. and Ironside, J.W. (2000) Inhibition of prion-protein conversion: a therapeutic tool? Trends Microbiol. 8, 6-8
7. Sc and delays onset of prion disease. EMBO J. 20, 3957-3966
8. d'Aignaux, J.N. et al. (2001) Predictability of the UK variant Creutzfeldt-Jakob disease epidemic. Science 294, 1729-1731
9. Lasmezas, C.I. et al. (2001) Adaption of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-Jakob disease: implications for human health. Proc. Natl. Acad. Sci. U. S. A. 98, 4142-4147
10. Enari, M. et al. (2001) Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc. Natl. Acad. Sci. U. S. A. 98, 9295-9299
11. Peretz, D. et al. (2001) Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412, 739-743
12. Sigurdsson, E.M. et al. (2002) Immunisation delays the onset of prion disease in mice. Am. J. Pathol. 161, 13-17
13. Sc propagation in prion-infected cells. J. Biol. Chem. 278, 18524-18531
14. Heppner, F.L. et al. (2001) Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science 294, 178-182
15. Sethi, S. et al. (2002) Postexposure prophylaxis against prion disease using a stimulator of innate immunity. Lancet 360, 229-230
16. White, A.R. et al. (2003) Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 422, 80-83
17. Ingram, D.K. (2001) Vaccine development for Alzheimer's disease: a shot of good news. Trends Neurosci. 24, 305-307
18. Dodart, J-C. et al. (2003) Immunotherapy for Alzheimer's disease: will vaccination work? Trends Mol. Med. 9, 85-87
19. Sc in vivo and antagonizes prion disease. Cell 113, 49-60
20. Sc accumulation. J. Virol. 72, 1153-1159
21. Zulianello, L. et al. (2000) Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of the prion protein. J. Virol. 74, 4351-4360
22. Perrier, V. et al. (2002) Dominant-negative inhibition of prion replication in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 99, 13079-13084
23. Soto, C. et al. (2000) Reversion of prion protein conformational changes by synthetic β-sheet breaker peptides. Lancet 355, 192-197
24. Sc formation. Chembiochem 3, 717-725
25. Supattapone, S. et al. (1999) Elimination of prions by branched polyamines and implications for therapeutics. Proc. Natl. Acad. Sci. U. S. A. 96, 14529-14534